the cabinet
Drugs
8,127 products tracked
Marketed
Mydayis ER
Mydayis ((amphetamine aspartate + amfetamine [INN] + dextroamphetamine saccharate + dextroamphetamine sulfate))
Attention Deficit Hyperactivity Disorder (ADHD)
Takeda Pharmaceuticals USA Inc
0 catalysts
Phase 2Mydicar
Systolic Heart Failure (HFrEF)
Sardocor Corp
0 catalysts
MarketedMyezom
Bortezomib (bortezomib)
Mantle Cell Lymphoma
Dr. Reddy's Laboratories Ltd
0 catalysts
Preclinical